India's Centre has started stakeholder talks with the medical device industry and private hospitals on trade-margin rationalisation, after Maharashtra's FDA flagged markups up to 2,841% on hospital consumables like IV…
Trump has reportedly directed OMB Director Russell Vought to draft an executive order creating a board, including NIH Director Jay Bhattacharya, with unanimous final authority over NIH grant funding, following…
Angle Health, an AI-native health benefits platform for small businesses founded by ex-Palantir engineers, has raised $600 million led by Vitruvian Partners at a $2.7 billion valuation, more than doubling…
All 50 states, DC, and Puerto Rico have applied to join the Trump administration's GENEROUS Medicaid drug-pricing model, which ties prices to what other developed nations pay, with projected savings…
The FDA has approved Eli Lilly's Inluriyo (imlunestrant) plus Verzenio (abemaciclib) for ER-positive, HER2-negative, ESR1-mutated advanced breast cancer, doubling median progression-free survival to 11.1 months in the Phase 3 EMBER-3…
ByteDance has raised $290 million for Anew Labs, its AI drug-discovery spinout, at a $1.5 billion valuation in its first external funding round, with ByteDance retaining a 56% stake and…
Novo has signed a multi-target discovery and licensing deal with Orbis Medicines worth up to $1.4 billion, using AI-designed macrocycle molecules to develop oral cardiometabolic drugs, one day after its…
The FDA has approved Fayuvi, a one-time AAV9 gene therapy from Ultragenyx, as the first-ever treatment for Sanfilippo syndrome Type A (MPS IIIA), a rare and fatal disease that progressively…
The FDA has approved Bayer's Kerendia (finerenone) for chronic kidney disease associated with type 1 diabetes, the first new treatment for this patient group in over 30 years, based on…
India's Centre has asked the NPPA to review hospital consumable pricing after Maharashtra's FDA found markups as high as 2,841% on IV sets, syringes, and catheters, a review that could…
